Navigation Links
Latest Pharmaceutical Launch Strategies Demonstrate Growing Importance of Thought Leader Engagement at Market Entry
Date:10/25/2011

CHAPEL HILL, N.C., Oct. 25, 2011 /PRNewswire/ -- While some newly-developed bio-pharmaceutical products thrive upon launch, many more struggle in today's crowded, competitive marketplace.  

In order to differentiate the treatment benefits of their new products, companies must think strategically about clinical and scientific thought leaders, targeting and engaging those who often serve as the gatekeepers to a product's acceptance in the medical community.

In fact, according to "Success Factors and Failure Points in Cardiovascular Product Launches," more than 80% of participating bio-pharmaceutical companies in Cardiology have found that engaging thought leaders in the actual protocol designs for late-Phase clinical trials is a highly effective method for building product and treatment momentum.

In addition, participating companies rate Advisory Boards and Clinical Trial Involvement as the most effective strategies for cultivating a successful environment at launch, according to this primary research conducted by Best Practices, LLC.

The study, which examines the product manufacturers in the Cardiology therapeutic area, provides insights to a critical core set of functions and activities during product launch, such as engagement of thought leaders and education of key stakeholders.

Download a complimentary study summary at http://www.best-in-class.com/dr354.htm that includes best practices drawn from extensive primary research with 44 executives and managers from 38 leading pharmaceutical, biotech and medical device companies.

Other key insights include:

  • Thought leader engagement is a critical success factor across all therapeutic areas. However, key relationship tactics score quite differently across Cardiology, Diabetes and the multi-therapeutic area class.
  • Payers and patient advocacy are becoming more important constituents for educating the market. Importantly, Diabetes and Cardiology accord different relative importance to each of these constituents.

The full 182-page report presents launch leaders' perspectives on the current and future risk levels for an array of pitfall factors that can affect a new product launch.  In all, the study contains more than 750 benchmark metrics and 39 executive narratives from leaders in the industry.

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.

BEST PRACTICES, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies.

The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Host Special Tomosynthesis Symposium and Feature the Latest in Womens Health Technologies at the Journees Francaises de Radiologie (JFR)
2. Latest Health and Wellness In-Car Technology from Ford to be Showcased Oct. 10-13 in San Diego
3. 2011 Medical Innovation Summit to Showcase Latest Innovations in Cardiovascular Care
4. New York Dermatologist Offers the Latest in Pelleve Wrinkle Reduction Technology
5. Contained Medication System Now Keeping Hospitals Compliant With Latest Legislation
6. Ruby+Associates Completes Latest Mercy Health Systems Design-Build Project
7. Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News
8. Latest Information on Obese Patients with Type 2 Diabetes and LAP-BAND System
9. Latest Releases of Elektas XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer
10. Enzymatics Reports Latest Growth Figures; Confirms Massachusetts Emerging Role as Leading Bio-manufacturing Center
11. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Aethlon Medical, Inc. (Nasdaq: ... Chairman and CEO, will be presenting at Source Capital Group,s ... York, NY at 2:15 p.m. ET on Wednesday, ... Immunotherapy Panel discussion taking place at 3:15 p.m. ET. ... approximately one hour after the conclusion of the live event. ...
(Date:2/5/2016)... Feb. 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... previously announced underwritten secondary offering of 11,027,558 shares of ... of affiliates of Blackstone and Goldman Sachs.  The shares ... price of $96.45 per share. The selling stockholders will ... Zimmer Biomet nor any of its directors, officers or ...
(Date:2/5/2016)... France , Germany ... and Israel ). It includes a 10-year epidemiology forecast ... segmented by age and sex in these markets. GD epidemiology report is ... in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends ... Germany , Italy , Spain ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV ... the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream ... Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors ...
(Date:2/5/2016)... CA (PRWEB) , ... February 05, 2016 , ... ... to announce the addition of micro-needling services in their Napa Valley office. The ... founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of ...
(Date:2/5/2016)... Miami, Florida (PRWEB) , ... February 05, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – is poised to once again host, Swirl, A Wine Tasting Event ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: ... wait longer to access the treadmills. It’s a predictable trend. After the excesses of ... and get in shape by joining gyms, starting new walking or running routines, or ...
(Date:2/5/2016)... , ... February 05, 2016 , ... At its annual ... Patrick McDermott as Chairman of the National Board of Directors. Mr. McDermott succeeds former ... the Board,” stated Leslie A. Chambers , APDA President and CEO. “Pat has ...
Breaking Medicine News(10 mins):